Medroxyprogesterone Acetate
Product Images NDC 52125-915

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 52125-915). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Medroxyprogesterone Ace is a prescription medication injection used for medical purposes. It contains 150 mg/1mL of the drug and is manufactured by Greenstone LLC in Peapack, NJ. The NDC number is 52125-0915-01 and the LOT number is 59762-4538-02. It can be stored at room temperature, between 20-25°C (68-77°F) with excursions permitted to 15-30°C (59-86°F) and comes with a package insert for directions. This particular injection was repackaged by RemedyRepack INC. in Indiana, PA.*
FDA Label Image

Figure 1 (Medroxyprogesterone 01)

Figure 1 (Medroxyprogesterone 01)
This appears to be a table or graph showing the odds ratio with 95% confidence intervals displayed on a logarithmic scale for various studies on the impact of DMPA use for more than 12 months on "all subjects." The table lists the odds ratios for each study, with a note that a ratio greater than 1 indicates an increased risk for DMPA. No further context or information is available.*
FDA Label Image

Chemical Structure (Medroxyprogesterone 02)

FDA Label Image

Logo (Medroxyprogesterone 03)

Logo (Medroxyprogesterone 03)
This text is a product label that includes the name of the brand, the distributor's name, and location. It does not provide specific information about the product itself.*
FDA Label Image

Figure (Medroxyprogesterone 04)

Figure (Medroxyprogesterone 04)
This is a chart showing various methods of contraception and their effectiveness in preventing pregnancy. The first section shows that fewer than 1 in 100 women using these methods will become pregnant in a year; the second section shows 10-20 in 100 women may become pregnant; and the last section shows 5 or more in 100 women may become pregnant. The methods listed include injections, intrauterine devices, sterilization, birth control pills, skin patch, vaginal ring with hormones, condoms, diaphragm, spermicide, withdrawal, and the absence of birth control. It is important to note that this information is likely part of a larger educational resource on family planning and should not be used as the sole source of information when making decisions about contraception.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.